Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1451 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Genmab, H Lundbeck sign antibody development agreement

The agreement allows Lundbeck to gain access to Genmab’s antibody creation and development capabilities, including its fully automated pre-clinical antibody screening and characterisation capabilities and its proprietary stabilised

HEPI gets PAZ patent issuance notification

The patent, titled ‘Composition and Use of Phyto-Percolate for the Treatment of Disease,’ describes the general makeup of PAZ and its ability to address a variety of common

Ortho Biotech releases COU-AA-301 study results

COU-AA-301 study was conducted in patients with metastatic advanced prostate cancer (also referred to as castration-resistant prostate cancer, or CRPC) previously treated with one or two chemotherapy regimens,